Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Improved CRBN ligands make protein degraders more effective and drug-like.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Ritlecitinib effectively regrows hair in severe alopecia areata, especially in adolescents.

Onyx® embolization effectively treats facial arteriovenous malformations with minimal complications.

Current treatments for recurrent ischemic priapism are not well-defined and need more research.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Propranolol affects heart rate and renin levels in minoxidil-treated patients.

The new compound may be a safer alternative to finasteride for prostate protection.

Valproic acid is a more effective treatment for vomiting in Alexander disease than other medications, with few side effects.

Platelets and their derivatives, like PRP, can help tissue regeneration, but need standardized safety protocols.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

The UK's EDS National Diagnostic Service found that early diagnosis, lifestyle advice, and regular check-ups are crucial for managing vascular Ehlers-Danlos syndrome. A combination of losartan and bisoprolol can reduce vascular events, improving survival and quality of life.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Deucravacitinib may effectively treat discoid lupus erythematosus.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Promising cancer treatments were found, but the manufacturer closed.

Five FDA-approved drugs may help block COVID-19 virus entry.